NFX — Nuformix Share News
0.000.00%
Last trade - 00:00NXP002 Update
Posting of Annual Report and Notice of AGM
Brief: Nuformix Announces 168,750 Stg Placing
£168,750 Placing
Annual Results for period ended 30 September 2024
NXP002 ODD Application Submitted
Brief: Nuformix Submits Draft Application For Orphan Drug Designation For NXP002
NXP002 Orphan Drug Designation Draft Application
Director/PDMR Dealings
£300,000 Fundraise
Brief: Nuformix Posts HY EPS GBP -0.0003
Half-year Report
Patent Update
Brief: Nuformix Announces Subscription To Raise Gross Proceeds Of £150,000
Subscription to raise £150,000
Posting of Annual Report and Notice of AGM
Results for the period ended 30 September 2023
Brief: Nuformix receives second NXP001 milestone payment from Oxilio
Brief: Nuformix Announces Notice Of Allowance Of NXP002 Patent In Japan